Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stonehaven Holdings is a Swiss holding company focused on building and backing animal health ventures through its subsidiary Stonehaven Incubate. The group was founded in 2015 and is associated with creating new stand-alone animal health companies by translating disruptive human biotech and health technologies into veterinary applications. Public materials describe activity spanning incubation, capital formation, strategy, and operational support for early-stage animal health startups rather than development of a single in-house therapeutic asset. Through Stonehaven Incubate, the group has disclosed work involving microbiome-derived products, anti-microbial technologies, and artificial intelligence-enabled peptide discovery for animal health. The company appears to operate primarily as a venture-building and strategic holding platform in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stonehaven Holdings.